Table 5.
Predictors | Model 1 | Model 2 | Model 3 |
---|---|---|---|
AUDIT-C score | |||
Medium: 4 | 77.1% (68.5–85.6) | 82.5% (76.4–88.6) | 78.9% (70.9–86.9) |
High: 6 | 84.8% (78.1–91.5) | 88.2% (83.0–93.4) | 83.5% (77.4–89.5) |
Very high: 10 | 90.9% (86.2–95.5) | 92.1% (88.2–96.1) | 88.2% (84.0–92.3) |
Sex | |||
Male | 86.3% (79.8–92.8) | 88.8% (83.8–93.9) | 84.4% (78.8–89.9) |
Female | 84.6% (77.5–91.8) | 89.5% (84.1–94.9) | 85.7% (79.3–92.0) |
Race/ethnicity | |||
African | 90.2% (81.9–98.6) | 93.2% (87.9–98.4) | 91.5% (82.2–100.8) |
African American | 84.1% (77.1–91.1) | 87.7% (81.3–94.0) | 84.3% (78.2–90.5) |
White | 80.7% (72.1–89.4) | 82.6% (73.4–91.8) | 76.8% (66.9–86.8) |
Other | 82.7% (73.7–91.7) | 83.9% (74.8–93.0) | 79.8% (66.9–92.7) |
Age | |||
20 | 78.4% (68.5–88.2) | 79.0% (67.6–90.5) | 83.0% (67.7–98.3) |
30 | 83.3% (76.9–89.8) | 85.9% (80.1–91.7) | 84.2% (75.7–92.8) |
40 | 86.0% (79.5–92.5) | 89.0% (83.9–94.0) | 84.7% (78.9–90.5) |
50 | 86.9% (80.0–93.8) | 89.7% (84.5–95.0) | 84.4% (78.9–89.9) |
60 | 86.4% (79.2–93.5) | 88.6% (83.2–93.9) | 83.3% (77.6–89.1) |
Method of blood collection | |||
Finger-prick | 86.6% (73.7–99.4) | ||
Venous blood collection | 85.7% (79.2–92.2) | ||
Body mass index (kg/m2) | |||
Underweight: 17.5 | 92.3% (88.4–96.1) | 89.3% (84.2–94.3) | |
Normal: 22 | 90.3% (85.8–94.9) | 86.5% (81.2–91.9) | |
Overweight: 27.5 | 87.1% (81.1–93.0) | 82.1% (76.2–87.9) | |
Obese: 33 | 83.2% (75.2–91.2) | 76.8% (70.1–83.6) | |
Hemoglobin (g/dL) | |||
Moderate/severe: 10 | 82.0% (74.1–89.8) | 74.9% (66.4–83.4) | |
Mild anemia: 11.5 | 84.8% (78.2–91.5) | 78.9% (71.8–86.0) | |
No anemia: 14 | 88.8% (83.7–94.0) | 84.5% (78.9–90.1) | |
High hemoglobin: 17.5 | 92.9% (89.0–96.8) | 90.3% (85.6–95.0) | |
HIV status | |||
Negative | 90.9% (86.4–95.5) | 87.1% (81.5–92.7) | |
Positive | 88.6% (83.4–93.8) | 84.3% (78.7–89.9) | |
FIB-4 score | |||
No/mild fibrosis: <1.45 | 83.1% (77.3–88.8) | ||
1.45–3.25 | 86.1% (80.2–92.1) | ||
Advanced fibrosis: >3.25 | 89.8% (84.8–94.8) |